3-chloro-4-fluoroaniline: intermediate in manufacture of flamprop isopropyl & flamprop methyl; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 9708 |
| SCHEMBL ID | 9602 |
| MeSH ID | M0085276 |
| Synonym |
|---|
| benzenamine, 3-chloro-4-fluoro- |
| nsc10290 |
| 3-chloro-4-fluoroaniline |
| nsc-10290 |
| aniline, 3-chloro-4-fluoro- |
| 367-21-5 |
| inchi=1/c6h5clfn/c7-5-3-4(9)1-2-6(5)8/h1-3h,9h |
| 3-chloro-4-fluoroaniline, 98% |
| C-3925 |
| AC-2469 |
| 3-chloro-4-fluorophenylamine |
| AKOS000119505 |
| nsc 10290 |
| einecs 206-682-8 |
| unii-7l63cc70uq |
| 7l63cc70uq , |
| 3-chloro-4-fluorobenzenamine |
| STL164339 |
| A15531 |
| FT-0615380 |
| 4-fluoro-3-chloroaniline |
| AM20060177 |
| SCHEMBL9602 |
| 3-chloro-4-fluoro-aniline |
| 3-chloro4-fluoro-aniline |
| 3chloro-4-fluoro-phenylamine |
| 4-fluoro-3-chlorophenyl amine |
| 4-fluoro-3-chloro phenyl amine |
| 3-chloro-4-fluoroanilin |
| 3-chloro-4-flouroaniline |
| 3-chloro-4-fluoro aniline |
| 4-fluoro-3-chloro-aniline |
| 4-fluoro-3-chlorophenylamine |
| 3-chloro4-fluoroaniline |
| m-chloro-p-fluoroaniline |
| PS-8955 |
| mfcd00007767 |
| DTXSID0038754 |
| CS-W009142 |
| F2190-0461 |
| P19616 |
| EN300-20338 |
| 3-chloro-4-fluoroaniline(chunks or pellets) |
| 3-chloro-4-fluoroaniline;benzenamine, 3-chloro-4-fluoro- |
| gefitinib impurity v |
| BCP26715 |
| norfloxacin intermediates |
| SB00006 |
| Q27268500 |
| HY-Y0680 |
| Z104477780 |
| Excerpt | Relevance | Reference |
|---|---|---|
| " Dosing at 5 mg kg(-1) with [(14)C]-labelled compound enabled the comparison of standard radioassay analysis methods with (19)F-NMR spectroscopy." | ( Metabolism of 3-chloro-4-fluoroaniline in rat using [14C]-radiolabelling, 19F-NMR spectroscopy, HPLC-MS/MS, HPLC-ICPMS and HPLC-NMR. Abou-Shakra, F; Duckett, CJ; Lindon, JC; Nicholson, JK; Walker, H; Wilson, ID, 2006) | 0.69 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (27.42) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||